Anish Babu

2.2k total citations
33 papers, 1.7k citations indexed

About

Anish Babu is a scholar working on Molecular Biology, Biomaterials and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anish Babu has authored 33 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 8 papers in Biomaterials and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anish Babu's work include RNA Interference and Gene Delivery (15 papers), Nanoparticle-Based Drug Delivery (8 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Anish Babu is often cited by papers focused on RNA Interference and Gene Delivery (15 papers), Nanoparticle-Based Drug Delivery (8 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Anish Babu collaborates with scholars based in United States, India and France. Anish Babu's co-authors include Rajagopal Ramesh, Anupama Munshi, Ranganayaki Muralidharan, Narsireddy Amreddy, Meghna Mehta, Akhil Srivastava, Amanda Templeton, Janani Panneerselvam, Yan D. Zhao and Allshine Chen and has published in prestigious journals such as Scientific Reports, Cancer Letters and Molecular Therapy.

In The Last Decade

Anish Babu

32 papers receiving 1.7k citations

Peers

Countries citing papers authored by Anish Babu

Since Specialization

Citations

This map shows the geographic impact of Anish Babu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anish Babu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anish Babu more than expected).

Fields of papers citing papers by Anish Babu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anish Babu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anish Babu. The network helps show where Anish Babu may publish in the future.

Co-authorship network of co-authors of Anish Babu

This figure shows the co-authorship network connecting the top 25 collaborators of Anish Babu. A scholar is included among the top collaborators of Anish Babu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anish Babu. Anish Babu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A review of ligand denticity in copper–Schiff Base complexes: Structural tuning toward enhanced antioxidant activity 2025 ·Inorganica Chimica Acta ·R. Mohan, (unknown), Anish Babu, (unknown), (unknown), (unknown)	1
2	Physical confinement during cancer cell migration triggers therapeutic resistance and cancer stem cell-like behavior 2021 ·Cancer Letters ·Qionghua Shen, (unknown), Xue Cai, Loan Bui, (unknown), (unknown), (unknown), Anish Babu, (unknown), (unknown), James Battiste, Young‐tae Kim	14
3	Regorafenib sensitizes human breast cancer cells to radiation by inhibiting multiple kinases and inducing DNA damage 2020 ·International Journal of Radiation Biology ·Meghna Mehta, (unknown), Janani Panneerselvam, Anish Babu, (unknown), Terence S. Herman, Rajagopal Ramesh, Anupama Munshi	28
4	Combinatorial Nanoparticle Delivery of siRNA and Antineoplastics for Lung Cancer Treatment 2019 ·Methods in molecular biology ·Rebaz Ahmed, Narsireddy Amreddy, Anish Babu, Anupama Munshi, Rajagopal Ramesh	13
5	Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth In Vitro and In Vivo By Disrupting the Oncogenic Activity of the RNA-binding Protein HuR 2017 ·Molecular Cancer Therapeutics ·Ranganayaki Muralidharan, Anish Babu, Narsireddy Amreddy, Akhil Srivastava, Allshine Chen, Yan D. Zhao, Uday B. Kompella, Anupama Munshi, Rajagopal Ramesh	55
6	Recent Advances in Nanoparticle-Based Cancer Drug and Gene Delivery 2017 ·Advances in cancer research ·Narsireddy Amreddy, Anish Babu, Ranganayaki Muralidharan, Janani Panneerselvam, Akhil Srivastava, Rebaz Ahmed, Meghna Mehta, Anupama Munshi, Rajagopal Ramesh	225
7	Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment 2017 ·Topics in Current Chemistry ·Narsireddy Amreddy, Anish Babu, Ranganayaki Muralidharan, Anupama Munshi, Rajagopal Ramesh	49
8	Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy 2017 ·Scientific Reports ·Anish Babu, Narsireddy Amreddy, Ranganayaki Muralidharan, Gopal Pathuri, Hariprasad Gali, Allshine Chen, Yan D. Zhao, Anupama Munshi, Rajagopal Ramesh	100
9	Multifaceted Applications of Chitosan in Cancer Drug Delivery and Therapy 2017 ·Marine Drugs ·Anish Babu, Rajagopal Ramesh	108
10	Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells 2016 ·Scientific Reports ·Akhil Srivastava, Narsireddy Amreddy, Anish Babu, Janani Panneerselvam, Meghna Mehta, Ranganayaki Muralidharan, Allshine Chen, Yan D. Zhao, Mohammad Razaq, Natascha Riedinger, Hogyoung Kim, Shaorong Liu, Si Wu, Asim B. Abdel‐Mageed, Anupama Munshi, Rajagopal Ramesh	157
11	Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration 2016 ·Journal of Nanobiotechnology ·Ranganayaki Muralidharan, Anish Babu, Narsireddy Amreddy, Kanthesh M. Basalingappa, Meghna Mehta, Allshine Chen, Yan D. Zhao, Uday B. Kompella, Anupama Munshi, Rajagopal Ramesh	77
12	Nanoparticles for siRNA-Based Gene Silencing in Tumor Therapy 2016 ·IEEE Transactions on NanoBioscience ·Anish Babu, Ranganayaki Muralidharan, Narsireddy Amreddy, Meghna Mehta, Anupama Munshi, Rajagopal Ramesh	64
13	Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy 2015 ·International Journal of Nanomedicine ·Rajagopal Ramesh, Narsireddy Amreddy, Ranganayaki Muralidharan, Anish Babu, Meghna Mehta, (unknown), Anupama Munshi, Yan Zhao	72
14	Nanodrug Delivery Systems: A Promising Technology for Detection, Diagnosis, and Treatment of Cancer 2014 ·AAPS PharmSciTech ·Anish Babu, Amanda Templeton, Anupama Munshi, Rajagopal Ramesh	69
15	Chitosan Coated Polylactic Acid Nanoparticle-Mediated Combinatorial Delivery of Cisplatin and siRNA/Plasmid DNA Chemosensitizes Cisplatin-Resistant Human Ovarian Cancer Cells 2014 ·Molecular Pharmaceutics ·Anish Babu, Qi Wang, Ranganayaki Muralidharan, Manish Shanker, Anupama Munshi, Rajagopal Ramesh	81
16	Polyethylene Glycol-Modified Gelatin/Polylactic Acid Nanoparticles for Enhanced Photodynamic Efficacy of a Hypocrellin Derivative <I>In Vitro</I> 2013 ·Journal of Biomedical Nanotechnology ·Anish Babu, (unknown), (unknown), Kumaresan Ganesan, Selvaraj Naicker, Paramasamy Gunasekaran, Ramachandran Murugesan	16
17	Gelatin Nanocarrier Enables Efficient Delivery and Phototoxicity of Hypocrellin B Against a Mice Tumour Model 2012 ·Journal of Biomedical Nanotechnology ·Anish Babu, K. Jeyasubramanian, Paramasamy Gunasekaran, Ramachandran Murugesan	18
18	Novel water soluble dendrimer nanocarrier for enhanced photodynamic efficacy of protoporphyrin IX 2012 ·Nano Biomedicine and Engineering ·M. Suresh Kumar, Anish Babu, Ramachandran Murugesan, K. Jeyasubramanian	11
19	Enhanced photodynamic efficacy and efficient delivery of Rose Bengal using nanostructured poly(amidoamine) dendrimers: potential application in photodynamic therapy of cancer 2011 ·Cancer Nanotechnology ·Karthikeyan Krishnamoorthy, Anish Babu, Sang‐Jae Kim, Ramachandran Murugesan, K. Jeyasubramanian	41
20	Characterization of DNA-Protein complexesinduced by Cr (VI) in liver tissue of rats 2009 ·I Control Pollution ·(unknown), (unknown), Anish Babu, (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact